- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03741387
The Effect of Message Framing on Blood Donation-Study 2
March 24, 2019 updated by: OUYANG Jian, Guangzhou Blood Center
Saving a Life or Preventing a Death: the Effect of Message Framing on Blood Donation Among Rh Negative Donors
Rh negative blood group is a rare blood group in China, as it only accounts for 0.3-0.4
percent of the Han population.
Therefore, low inventory is often found in blood collection and supply agencies in many regions in China.
In order to assess the effects of the gain-versus-loss framing message on blood donation among Rh negative donors, we designed two kinds of self-administered, standardized and structured questionnaires.
In addition of the basic socio-demographic characteristics, one questionnaire includes the questions which survey the attitude of saving patients lives, and the other was to survey the attitude of preventing patients from death.
The questionnaires were randomly sent to Rh negative blood donors.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
795
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510095
- Guangzhou Blood Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Rh negative blood donors who have donated blood between 2016 and 2018.
Exclusion Criteria:
- People who are Rh negative blood type but never have donated blood.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Gain-frame questionnaire
Questionnaire included a picture of a patient lying in bed entitled "Will you save his life?"
Donors in this group will answer the questions about attitude of saving patients' lives.
|
Questionnaires focusing on the attitude of saving patients' lives were given to Rh negative blood donors in this group.
|
|
Experimental: Loss-frame questionnaire
Questionnaire included a picture of a patient lying in bed entitled "Will you prevent him from death?" Donors in this group will answer the questions about the attitude of preventing patients from death.
|
Questionnaires focusing on the attitude of preventing patients from death were given to Rh negative blood donors in this group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The differences of attitude towards different massage framing
Time Frame: 1 day
|
After participants view the picture in their questionnaires, they would answer the questions about attitude of saving patients' lives or preventing patients from death.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2019
Primary Completion (Actual)
March 21, 2019
Study Completion (Actual)
March 21, 2019
Study Registration Dates
First Submitted
November 11, 2018
First Submitted That Met QC Criteria
November 11, 2018
First Posted (Actual)
November 14, 2018
Study Record Updates
Last Update Posted (Actual)
March 26, 2019
Last Update Submitted That Met QC Criteria
March 24, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- Message Framing effect 2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rh Negative Blood Donor
-
Guangzhou Blood CenterCompleted
-
Fundació Institut de Recerca de l'Hospital de la...UnknownPregnant Women | Rh-Hr Blood-Group SystemSpain
-
Guangzhou Blood CenterCompleted
-
Institute of Liver and Biliary Sciences, IndiaCompletedHealthy Blood DonorIndia
-
Haemonetics CorporationCompletedTransmission, Blood, Recipient/DonorUnited States
-
Haemonetics CorporationCompletedTransmission, Blood, Recipient/DonorUnited States
-
Haemonetics CorporationCompletedTransmission, Blood, Recipient/DonorUnited States
-
National Research Centre, EgyptCairo UniversityCompletedFetal Anemia as Antepartum Condition (Diagnosis) | Rh Incompatible Blood Transfusion NosEgypt
-
Haukeland University HospitalCompletedAutologous Blood Transfusion | Physical Performance | Donor SafetyNorway
Clinical Trials on Gain-frame questionnaire
-
Guangzhou Blood CenterCompleted
-
University of California, DavisNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHealth Knowledge, Attitudes, Practice | IntentionUnited States
-
M.D. Anderson Cancer CenterLance Armstrong FoundationUnknown
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Boston CollegeCompleted
-
Odense University HospitalUniversity of Southern DenmarkRecruitingQuality of Life | Physical Activity | Physical Disability | Physical Function | ParticipationDenmark
-
Oslo University HospitalSahlgrenska University Hospital, SwedenCompleted
-
Queen Margaret UniversityMultiple Sclerosis Society of Great BritainCompletedMultiple SclerosisUnited Kingdom
-
Yale-NUS CollegeCompleted
-
Vascular Graft Solutions Ltd.SuspendedPeripheral Arterial Disease | Peripheral Artery DiseaseUnited States